BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31199045)

  • 1. Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression.
    Männistö V; Kaminska D; Kärjä V; Tiainen M; de Mello VD; Hanhineva K; Soininen P; Ala-Korpela M; Pihlajamäki J
    Liver Int; 2019 Oct; 39(10):1895-1905. PubMed ID: 31199045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
    Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
    van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic PEMT Expression Decreases with Increasing NAFLD Severity.
    Piras IS; Raju A; Don J; Schork NJ; Gerhard GS; DiStefano JK
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle.
    Kim YC; Seok S; Byun S; Kong B; Zhang Y; Guo G; Xie W; Ma J; Kemper B; Kemper JK
    Nat Commun; 2018 Feb; 9(1):540. PubMed ID: 29416063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine
    van der Veen JN; Lingrell S; Gao X; Takawale A; Kassiri Z; Vance DE; Jacobs RL
    J Lipid Res; 2017 Apr; 58(4):656-667. PubMed ID: 28159867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.
    Nakatsuka A; Matsuyama M; Yamaguchi S; Katayama A; Eguchi J; Murakami K; Teshigawara S; Ogawa D; Wada N; Yasunaka T; Ikeda F; Takaki A; Watanabe E; Wada J
    Sci Rep; 2016 Feb; 6():21721. PubMed ID: 26883167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
    Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
    Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine.
    Arendt BM; Ma DW; Simons B; Noureldin SA; Therapondos G; Guindi M; Sherman M; Allard JP
    Appl Physiol Nutr Metab; 2013 Mar; 38(3):334-40. PubMed ID: 23537027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylethanolamine N-methyltransferase gene rs7946 polymorphism plays a role in risk of nonalcoholic fatty liver disease: evidence from meta-analysis.
    Tan HL; Mohamed R; Mohamed Z; Zain SM
    Pharmacogenet Genomics; 2016 Feb; 26(2):88-95. PubMed ID: 26636496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.
    Bale G; Vishnubhotla RV; Mitnala S; Sharma M; Padaki RN; Pawar SC; Duvvur RN
    J Clin Exp Hepatol; 2019; 9(5):561-568. PubMed ID: 31695245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Phosphatidylethanolamine N-Methyltransferase (
    Sun C; Holstein DJF; Garcia-Cubero N; Moulla Y; Stroh C; Dietrich A; Schön MR; Gärtner D; Lohmann T; Dressler M; Stumvoll M; Blüher M; Kovacs P; Guiu-Jurado E
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological roles of phosphatidylethanolamine N-methyltransferase.
    Vance DE
    Biochim Biophys Acta; 2013 Mar; 1831(3):626-32. PubMed ID: 22877991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population.
    Dong H; Wang J; Li C; Hirose A; Nozaki Y; Takahashi M; Ono M; Akisawa N; Iwasaki S; Saibara T; Onishi S
    J Hepatol; 2007 May; 46(5):915-20. PubMed ID: 17391797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD).
    Song J; da Costa KA; Fischer LM; Kohlmeier M; Kwock L; Wang S; Zeisel SH
    FASEB J; 2005 Aug; 19(10):1266-71. PubMed ID: 16051693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance.
    Wan S; van der Veen JN; Bakala N'Goma JC; Nelson RC; Vance DE; Jacobs RL
    FASEB J; 2019 Oct; 33(10):10986-10995. PubMed ID: 31284753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling.
    van der Veen JN; Lingrell S; McCloskey N; LeBlond ND; Galleguillos D; Zhao YY; Curtis JM; Sipione S; Fullerton MD; Vance DE; Jacobs RL
    FASEB J; 2019 Apr; 33(4):5045-5057. PubMed ID: 30615497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
    Männistö VT; Simonen M; Hyysalo J; Soininen P; Kangas AJ; Kaminska D; Matte AK; Venesmaa S; Käkelä P; Kärjä V; Arola J; Gylling H; Cederberg H; Kuusisto J; Laakso M; Yki-Järvinen H; Ala-Korpela M; Pihlajamäki J
    Liver Int; 2015 Jul; 35(7):1853-61. PubMed ID: 25533197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
    Li Z; Agellon LB; Allen TM; Umeda M; Jewell L; Mason A; Vance DE
    Cell Metab; 2006 May; 3(5):321-31. PubMed ID: 16679290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.